Digital molecular imaging systems developer Gamma Medica-Ideas Inc. of Northridge, Calif., has signed an exclusive licensing and commercialization agreement with the Mayo Clinic to further develop and commercialize a suite of technologies invented by a team of Mayo physicians and scientists. The company will use the licensed technology in conjunction with its Lumagem molecular breast imaging system to improve cancer diagnosis in women with dense breasts.